Both in Pharmaceuticals

Corbus Pharmaceuticals Holdings vs Rani Therapeutics Holdings

Over the past year CRBP returned −75.3% and RANI returned +38.7%; their daily moves had a correlation of 0.07.

CRBP −75.3% RANI +38.7%Growth of $1, one year, split-adjusted
MetricCRBPRANI
Price$4.33$0.6800
Market cap$83.7M$78.5M
Today−1.81%+1.46%
1 month−40.4%−10.1%
6 months−57.3%−26.0%
Year to date−46.8%−49.6%
1 year−73.4%+40.4%
Revenue growth (YoY)——
Gross margin—100.0%
Net margin—−432.7%
P/E (TTM)——
Price / sales—16.1×
Net cash$117.9M$53.4M
Dividend yield——
Volatility (60d)72.9%62.5%
Short % of float18.8%9.3%
Next earnings——

Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).